Patient Presentation of COVID-19 with Liver Cirrhosis

Abstract

COVID-19 has shown diverse clinical presentations, particularly in patients with underlying comorbidities. This case study describes a patient with liver cirrhosis presenting with COVID-19, emphasizing the complexity of diagnosis and management. The case highlights how comorbid conditions can alter disease progression and clinical outcomes[1]

Introduction

Case reports serve as an essential medium for sharing clinical experiences and understanding rare or complex disease presentations. COVID-19, caused by SARS-CoV-2, has demonstrated varied clinical manifestations, especially in patients with chronic illnesses[2].

Patients with liver cirrhosis are particularly vulnerable due to immune dysfunction and impaired metabolic processes.

Case Presentation

Patient Information

A 60-year-old female presented with:

Fever (38.5°C)

Dry cough

Fatigue

Shortness of breath

Medical History

Liver cirrhosis (5 years)

Diabetes mellitus

No history of recent travel

Clinical Findings

Oxygen saturation: 88% on room air

Respiratory rate: 24/min

Mild jaundice

Ascites present

Laboratory findings:

Elevated liver enzymes

Lymphopenia

Prolonged coagulation profile

Diagnostic Assessment

RT-PCR confirmed COVID-19 infection. Imaging showed bilateral lung infiltrates. The patient’s condition was complicated by liver dysfunction, which affected immune response and coagulation[3].

Studies have shown that COVID-19 patients with cirrhosis exhibit abnormal laboratory findings such as reduced lymphocyte count and coagulation abnormalities.

Therapeutic Intervention

Treatment included:

Oxygen therapy

Antiviral medications

Plasma therapy

Supportive care

Due to cirrhosis, medication dosages were carefully adjusted.

Follow-Up and Outcomes

Hospital stay: 32 days

Gradual clinical improvement

Negative COVID-19 test after treatment

The patient was discharged with stable liver function and respiratory status.

DISCUSSION

This case demonstrates how underlying conditions like cirrhosis significantly impact COVID-19 progression. Liver dysfunction leads to impaired immune response, increasing disease severity.

Case studies such as this provide valuable insights into managing patients with multiple comorbidities and contribute to evidence-based medicine[4].

References

1. Kreivenaite E, Gedgaudas R, Valantiene I et al. (2020). COVID-19 in a Patient with Liver Cirrhosis. Journal of Gastrointestinal and Liver Diseases.

   Indexed at, Google Scholar, Crossref

2. Beraldo RF, Marcondes MB, Dos Santos MNM et al. (2021). COVID-19 in a Patient with Liver Cirrhosis. American Journal of Case Reports.

   Indexed at, Google Scholar, Crossref

3. Zhou J, Jiang D, Wang W et al. (2021). Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis. Frontiers in Medicine.

   Google Scholar, Crossref

4. Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-Troche JM (2020). Hepatic Manifestations and Impact of COVID-19 on the Cirrhotic Patient. Revista de Gastroenterología de México.

   Google Scholar, Crossref

5. Shalimar, Elhence A, Vaishnav M et al. (2020). Poor Outcomes in Patients with Cirrhosis and COVID-19 Indian. Journal of Gastroenterology.

   Indexed at, Google Scholar, Crossref